Israel Englander Isoray, Inc. Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	5,794,725 New	5,794,725 $4 Million
Q4 2022 Feb 14, 2023	SELL	$0.24 - $0.4 $1,980 - $3,301	-8,254 Reduced 37.59%	13,705 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.22 - $0.43 $3,367 - $6,582	-15,307 Reduced 41.07%	21,959 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.37 $223 - $318	-860 Reduced 2.26%	37,266 $12,000
Q1 2022 May 16, 2022	BUY	$0.31 - $0.41 $5,172 - $6,841	16,687 Added 77.83%	38,126 $14,000
Q4 2021 Feb 14, 2022	BUY	$0.38 - $0.68 $8,146 - $14,578	21,439 New	21,439 $8,000
Q4 2019 Feb 14, 2020	SELL	$0.3 - $0.69 $6,344 - $14,592	-21,149 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.31 - $0.42 $6,556 - $8,882	21,149 New	21,149 $6,000

145K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.